Gainers
- BioCardia BCDA shares rose 29.91% to $2.91 during Wednesday's after-market session. At the close, BioCardia's trading volume reached 793.9K shares. This is 471.05% of its average volume over the last 100 days. The company's market cap stands at $49.0 million.
- AnPac Bio-Medical Science ANPC shares moved upwards by 8.91% to $1.1. The market value of their outstanding shares is at $19.5 million.
- BioSig Technologies BSGM shares rose 5.19% to $2.43. The market value of their outstanding shares is at $85.8 million.
- Quoin Pharmaceuticals QNRX stock moved upwards by 4.71% to $2.0. The company's market cap stands at $16.6 million.
- Evoke Pharma EVOK shares increased by 4.45% to $0.64. The market value of their outstanding shares is at $20.7 million.
- Genfit GNFT shares rose 4.26% to $5.87. The company's market cap stands at $268.5 million.
Losers
- Advaxis ADXS shares declined by 30.0% to $0.17 during Wednesday's after-market session. Advaxis's trading volume hit 3.9 million shares by close, accounting for 87.55% of its average volume over the last 100 days. The market value of their outstanding shares is at $24.4 million.
- Ensysce Biosciences ENSC stock fell 7.65% to $4.47. Trading volume for this security closed at 365.8K, accounting for 6.42% of its average full-day volume over the last 100 days. The company's market cap stands at $108.4 million.
- Roivant Sciences ROIV shares declined by 5.15% to $11.24. The market value of their outstanding shares is at $7.6 billion.
- BiondVax Pharmaceuticals BVXV shares decreased by 4.46% to $2.79. At the close, BiondVax Pharmaceuticals's trading volume reached 359.4K shares. This is 459.89% of its average volume over the last 100 days. The company's market cap stands at $39.9 million.
- Midatech Pharma MTP shares fell 4.1% to $1.17. The company's market cap stands at $14.8 million.
- BioRestorative Therapies BRTX shares fell 3.54% to $5.18. The market value of their outstanding shares is at $18.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in